Search results

Amid growing concern that the pharmaceutical industry’s pricing, tax and lobbying practices are undermining the health of millions of people in the US and across the globe, this briefing presents new findings on how the biggest corporate tax cut in a generation has benefited four of America’s pharmaceutical giants.

Onus of incorporating strong rules to limit speculation on food commodities into Markets in Financial Instruments Directive (MiFID) now lies with Member States

Oxfam spokesperson Mark Fried said:  

Oxfam hailed today’s ruling against mining company OceanaGold, which effectively ended the company’s lawsuit against El Salvador for not granting it a mining permit.

The European Commission, Parliament and member states agreed on rules to ban unfair trading practices in the EU food supply chain, which will help end the human suffering behind our food.

About innovative financing for development and climate change EU Finance Ministers today agreed their common position for the upcoming G20 Finance Ministers meeting on 14-15 October in Pa

Oxfam welcomed today’s vote by European Parliamentarians in support of a strong European Financial Transaction Tax (FTT) covering all instruments (shares, bonds and derivatives), as put forward by

Governments tried to further water down an already weak legislative proposal, Oxfam said in response to the EU finance ministers’ failure to agree on new measures against corporate tax dodging.

The India climate action plan for Paris announced today contains the headline pledge to cut the carbon intensity of its economy by 33-35% by 2030. 

Pharmaceutical giant Novartis is back in court this week, in a renewed attempt to block India’s right to produce affordable ‘generic’ versions of the company’s branded medicines.